<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01552564</url>
  </required_header>
  <id_info>
    <org_study_id>1625</org_study_id>
    <nct_id>NCT01552564</nct_id>
  </id_info>
  <brief_title>The Microcirculation in Acute Myocardial Infarction (Micro-AMI)</brief_title>
  <acronym>Micro-AMI</acronym>
  <official_title>The Microcirculation in Acute Myocardial Infarction (Micro-AMI)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Bristol</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Bristol</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the association between the microvascular resistance at the time of
      primary percutaneous intervention, with microvascular obstruction on CMR and blood markers of
      myocardial damage.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>March 2012</start_date>
  <primary_completion_date type="Actual">January 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Microvascular obstruction</measure>
    <time_frame>DAy 2-4</time_frame>
    <description>Microvascular obstruction as a percentage of the left ventricle at 2-4 days.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">50</enrollment>
  <condition>STEMI</condition>
  <arm_group>
    <arm_group_label>STEMI patients</arm_group_label>
    <description>Consecutive patients presenting through the PPCI service</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Index of microvascular resistance</intervention_name>
    <arm_group_label>STEMI patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Cardiac magnetic resonance</intervention_name>
    <arm_group_label>STEMI patients</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood markers</intervention_name>
    <arm_group_label>STEMI patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        STEMI attending Bristol Heart Institute via the primary PCI service
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt;18 years old

          -  Cardiac symptoms of &gt; 20 mins chest pain or equivalent.

          -  ECG criteria consistent with STEMI (STEMI)

          -  Proceeding with percutaneous angioplasty

          -  Assent/ consent to the study

        Exclusion Criteria:

          -  Known allergy to adenosine or gadolinium

          -  Chronic atrial fibrillation

          -  Renal impairment with eGFR &lt;30

          -  Contraindication to angiography

          -  Contraindication to CMR (implanted pacemaker/ defibrillator, ferromagnetic metal
             implant/ injury, claustrophobia, obesity/ too large for CMR scanner)

          -  Cardiogenic shock

          -  Patients with special communication needs or altered consciousness.

          -  Patients who do not give assent/consent to the study
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bristol Heart Institute</name>
      <address>
        <city>Bristol</city>
        <zip>BS2 8HW</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>October 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 9, 2012</study_first_submitted>
  <study_first_submitted_qc>March 12, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 13, 2012</study_first_posted>
  <last_update_submitted>October 27, 2014</last_update_submitted>
  <last_update_submitted_qc>October 27, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Bristol</investigator_affiliation>
    <investigator_full_name>Elisa McAlindon</investigator_full_name>
    <investigator_title>Clinical Research Fellow</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

